21 May 2013
Keywords: roche, r1507, effective, ph, against, solid, tumors
Article | 05 November 2007
Swiss drug major Roche says that Phase I data from a trial of R1507, a monoclonal antibody that targets the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 October 2007
12 November 2007
20 May 2013
© 2013 thepharmaletter.com